Paul Imber, DO
Otolaryngology · Wilmington, DENPI 1245308147
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,511 of the $5,191 with a category attached, or 67.6%. 35 manufacturers reported payments, led by Intersect ENT, Inc. at 42.0% of the total. Reporting peaked in 2019 at $2,401 and has fallen 76.1% since, to $574 in 2025. Among otolaryngology clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $37.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$2K
- Biocryst US Sales Co., LLC$626
- CSL Behring$480
- Takeda Pharmaceuticals U.S.A., Inc.$322
- Optinose US, Inc.$214
- Novartis$186
- plus $1K from 29 others
What the payments were for
- Travel & lodging$1,68032%
- Food & beverage$3,51168%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 8 | $2,182 |
| Biocryst US Sales Co., LLC | 20 | $626 |
| CSL Behring | 18 | $480 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $322 |
| Optinose US, Inc. | 13 | $214 |
| Novartis | 11 | $186 |
| Medtronic | 1 | $165 |
| Kaleo, Inc. | 8 | $130 |
| GSK | 6 | $117 |
| Stryker | 1 | $83 |
| Pharming Healthcare, Inc. | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $58 |
| Sanofi | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Grifols USA, LLC | 2 | $37 |
| Ionis Pharmaceuticals, Inc. | 2 | $35 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Alk-abello, Inc | 2 | $32 |
| Amgen | 1 | $30 |
| Incyte Corporation | 1 | $27 |
| Bio Products Laboratory USA, Inc. | 2 | $26 |
| Upsher-smith Laboratories LLC | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Blueprint Medicines Corporation | 1 | $23 |
| Octapharma USA, Inc. | 1 | $21 |
| LEO Pharma Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
| Neos Therapeutics, LP | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $11 |
| Glenmark Therapeutics Inc. | 1 | $11 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,191 in reported general payments places this provider in the 90th percentile of 27 otolaryngology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 110 | $6,288 |
| Ipratropium Bromide | 80 | $2,848 |
| Mometasone Furoate | 52 | $2,166 |
| Famotidine | 211 | $2,070 |
| Fluticasone Propionate | 120 | $1,899 |
| Pantoprazole Sodium | 112 | $1,758 |
| Omeprazole | 96 | $1,316 |
| Mupirocin | 53 | $465 |
| Montelukast Sodium | 12 | $426 |
| Prednisone | 42 | $159 |
| Chlorhexidine Gluconate | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Wilmington
- Udayan ShahWilmington$5K
- Joan CokerWilmington$3K
- Michael TeixidoWilmington$3K
- Mindy RabinowitzWilmington$3K
- Neil HocksteinWilmington$2K
- Kieran ConnollyWilmington$2K
- Lauren BogdanWilmington$2K
- Emilio ValdesWilmington$413
- Timoteo GabrielWilmington$157
- James ReillyWilmington$95
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.